Comparing vascular markers and lipids
The researchers compared people with pediatric or childhood-onset IBD with controls. Their literature search, conducted across several scientific databases through April 24, 2025, covered vascular markers, blood pressure and blood lipid levels.
The sample size and number of studies varied depending on the parameter analyzed. The available abstract does not specify how long participants were followed. It therefore cannot describe how these markers change over the years.
A lower vascular reactivity index
The main signal concerns the reactive hyperemia index, or RHI. Across three studies involving 109 participants, this index was on average 0.25 lower in people with IBD, with a 95% confidence interval ranging from −0.48 to −0.02.
According to the authors, this finding suggests possible early endothelial dysfunction, meaning impaired function of the inner lining of blood vessels. However, it is an intermediate marker, not a measure of future heart attacks or other cardiovascular events. The authors themselves describe the evidence as preliminary.
The other findings do not confirm a uniformly impaired profile
The six studies examining carotid intima-media thickness showed no statistically significant difference. The main analyses also detected no significant difference in diastolic blood pressure or blood lipids. This is not enough to establish equivalence between the groups.
For systolic blood pressure, the main analysis of ten studies found a mean difference of 0.84 mmHg, which was not statistically significant. After one influential study was excluded, a small difference of 1.89 mmHg emerged. This sensitivity to study selection limits the robustness of the conclusion.
A signal to follow up, not an individual prediction
Above all, this review supports further research. Prospective cohorts are needed to determine whether the observed differences persist and truly predict more cardiovascular disease in adulthood. On its own, it does not provide a basis for a new screening or treatment protocol.
Limitations to keep in mind
Only the PubMed abstract was consulted, not the full text. The RHI finding is based on three studies and 109 participants. Details of heterogeneity, treatments and confounding factors are not available in the dossier. Funding and conflicts of interest were not checked.
What we can take away
A lower vascular index emerges from a small set of studies on pediatric IBD. This signal warrants confirmation and should not be equated with demonstrated future cardiovascular risk.
Sources and provenance
- Cardiovascular and lipid parameters in pediatric inflammatory bowel disease: systematic review & meta-analysis.
Source date: 2026-11-20.
Journal Article, Systematic Review, Meta-Analysis, Review · Résumé PubMed uniquement, texte intégral non consulté


